The
first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched
to West Africa and is expected to arrive in Liberia on Friday, the
British drug-maker said.
The World Health
Organization said on Thursday the Ebola outbreak in West Africa, the worst in
history, appears to be waning but cautioned against complacency. The epidemic
has seen 21,724 cases reported in nine countries since it started in Guinea a
year ago. Some 8,641 people have died.
The shipment of an
initial 300 vials of GSK vaccine will be the first to arrive in one of the
three main Ebola-affected African countries, the company said in a statement.
GlaxoSmithKline (GSK) hopes the vaccine trials will prove effective in
combating the virus but stressed it was still in development.
No comments:
Post a Comment